PlainRecalls
FDA Drug Moderate Class II Ongoing

Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.

Reported: October 29, 2025 Initiated: September 15, 2025 #D-0037-2026

Product Description

Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.

Reason for Recall

Failed Tablet/Capsule Specifications

Details

Units Affected
46,512/30 count bottles
Distribution
Product was distributed to 1 distributor and 16 wholesalers/pharmacy retailers nationwide.
Location
Hyderabad

Frequently Asked Questions

What product was recalled?
Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg, 30-count bottles, Rx Only, Mfd. by: Graviti Pharmaceuticals Private Limited, Sangareddy, Telangana, India, Dist. by: Rising Phar, NDC 16571-863-03.. Recalled by Graviti Pharmaceuticals Private Limited. Units affected: 46,512/30 count bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on October 29, 2025. Severity: Moderate. Recall number: D-0037-2026.